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Solitary Metastasis from Cutaneous
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(Trisegmentectomy) with Clearance of Tumor
from the Portal Vein
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A 61-year-old woman presented with low grade fever and an epigastric mass eight years
following resection ofa stage Clark IV infraclavicular cutaneous melanoma followed by axillary
node dissection. Investigations revealed a tumor in segment II, III, IV and V of the liver and
a thrombus involving the main portal vein. Liver resection with extended left hepatectomy (left
trisegmentectomy) and portal vein thrombectomy is reported.
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INTRODUCTION
Metastatic cutaneous melanoma to the liver usually
presents as multiple hepatic recurrences and in associ-
ation with widespread metastatic disease 1. In con-
trast, occular melanoma often recurs in the liver as the
only metastatic site after a long disease-free interval2.
Rarely, hepatic metastases from melanoma are resect-
able3.
In this report, a patient with a long disease-free
interval following resection of an infraclavicular cuta-
neous melanoma and axillary node dissection presented
with a single liver metastasis and carcinomatous portal
vein thrombosis. Resection with extended left hepa-
tectomy (left trisegmentectomy) and portal vein recon-
struction is reported.
* Present Address: Jean-Nicolas Vauthey, MD, Assistant Profes-
sor Department of Surgery, P.O. Box 100286, University of Florida
College of Medicine, Gainesville, Florida 32610-0286, USA.
CASE REPORT
A 61 year old woman presented with low grade fever,
myalgia and a 6cm epigastric mass. Six years prior to
this, she had had resection of a Clark’s IV infraclavicu-
lar cutaneous melanoma and an axillary node dissec-
tion with 3 out of 40 positive nodes. At presentation,
laboratory tests were significant for raised lactic
dehydrogenase (LDH) (766 U/L, normal value 60 to
200 U/L). Alphafetoprotein (AFP) was 3.1 ng/ml (nor-
mal value 0.0 to 8.5 ng/ml). Hepatitis B and C serology
were negative. Dynamic computed tomography (CT)
showed a mass in the left liver extending to involve
segment V of the right liver. CT of the head and chest
showed no evidence of metastatic disease. CT porto-
graphy showed hypoperfusion and a mass in the left
lobe of the liver with extension into segment V of the
right lobe and a portal vein thrombus (Figure 1).
Selective mesenteric arteriography shown in Figure 2
reveals replacement of the right hepatic artery with
origin from the superior mesenteric artery.
5354 JEAN-NICOLAS VAUTHEY et al.
Figure CT portography illustrating tumor involving segments II, III, IV and V and left portal vein thrombus extending into main portal
vein (arrow).
Figure 2 Selective superior mesenteric arteriography showing replaced right hepatic artery arising from superior mesenteric artery with
anterior branch supplying part ofthe tumor. The remaining liver is supplied by anatomically normally arising left hepatic artery (not shown).SOLITARY METASTASIS 55
Figure 3 Extraction of thrombus (arrow).
An extended left hepatectomy (left trisegmentec-
tomy) was performed. The procedure consisted of re-
moval of segments II, III, IV, V and VIII. The origin of
the left portal vein was divided after vascular control
was obtained by clamping the main portal vein and
right portal vein. The thrombus extending into the
main portal vein was extracted by a venotomy at the
bifurcation of the main and left portal vein and the
portal vein was reconstructed (Figure 3). The left and
middle hepatic veins were divided extrahepatically.
The vascularly isolated left liver along with segments
V and VIII were then resected in a plane anterior to the
right portal scissure securing the anterior sectoral
branch of the right portal pedicle within the liver
substance. Blood loss amounted to 450cc during mo-
bilization of the liver and 550cc during parenchymal
dissection. The patient received a total of 2 units of
autologous blood perioperatively. Pathology showed
bilobar metastatic melanoma with left portal vein tu-
mor thrombus. Hepatic and portal vein resection mar-
gins were negative. Lymph nodes from the hilus of the
liver showed no evidence of malignancy.
The patient was discharged on postoperative day 14
with a biliary fistula draining less than 200 ccs per day.
HIDA-scan showed a minor biliary fistula with normal
uptake of the isotope in the remaining liver and unim-
paired excretion into the intestine. Bile drainage sub-
sided spontaneously on postoperative day 34.
DISCUSSION
The liver is the only site of extraregional metastases in
1 to 4% of patients with cutaneous melanoma4’5’6, but
advanced melanoma is known to widely metastasize to
multiple sites 7. Autopsy studies have shown diffuse
hepatic liver involvement in 52 to 68% of advanced
metastatic cutaneous melanoma’’5’8 while liver failure
is a cause of death in 7%4.
Isolated liver involvement by metastatic cutaneous
melanoma is rare but occular melanoma has a unique
pattern of isolated metastasis to the liver following
a long disease-free interval2. In this case, a portal vein
thrombosis initially suggested primary hepatocellular
carcinoma. While hepatic resection can provide long-
term survival in hepatocellular carcinomas, survival
after resection of isolated hepatic metastases from
cutaneous melanoma is unknown.
Comparison between chemotherapy and resection
of isolated distant metastases from cutaneous melan-
oma shows a better palliation and prolonged survival
after resection 1’9. After complete resection of a single
extraregional metastasis from cutaneous melanoma,
a long-term survival of 20 to 25% is expected1.
Caputy et al. found that a disease-free interval of
longer than 2 years between treatment of the primary
melanoma and the development of gastrointestinal
metastases was associated with improved survival.56 JEAN-NICOLAS VAUTHEY et al.
Presence or absence of nodal metastases at the time of
primary melanoma diagnosis had no significant im-
pact on the duration of patient survival once gastroin-
testinal metastases developed. Branum etal. 12 re-
ported on gastrointestinal metastases and found that if
all known disease was resected, median survival was
17 months. Incomplete resection had a median survival
of 7 months comparable to no resection and bypass
procedures.
In this patient, the metastasis was isolated and com-
pletely resectable by extended left hepatectomy (tri-
segmentectomy) and portal vein thrombectomy. Ex-
tended left hepatectomy is a complex procedure with
the attending risks of heavy blood loss and bile duct
injuries 13. The resection line is anterior to the right
portal scissure in a plane parallel to the right hepatic
vein 14’15. Blood loss during the procedure results
mainly from hepatic venous bleeding. It can be greatly
minimized by complete extrahepatic vascular isola-
tion. In this patient, the left and middle hepatic vein
were isolated before parenchymal transection and ad-
ditional margins were obtained by dividing the anter-
ior sectoral branch ofthe right portal pedicle within the
liver substance as recently reported15,16.
Portal vein thrombosis occurs in association with
cirrhosis, neoplasm, infection, inflammation (pancre-
atitis), myeloproliferative disorders or idiopathically17.
Carcinomatous thrombosis commonly occurs in asso-
ciation with advanced pancreatic carcinoma and hepa-
tocellular carcinoma secondary to direct portal vein
invasion by tumor Or extrinsic compression of the
portal vein18,19,2o. Carcinomatous thrombosis from
metastases is uncommon17 and in this case the associ-
ation with melanoma is unusual. Patients with malig-
nant portal vein thrombosis are less likely to survive
long enough to develop the sequelae of portal hyper-
tension and variceal hemorrhage is rare21. Exception-
nally, portal vein thrombi are resectable. Techniques of
portal vein tumor thrombus extraction include balloon
catheter extraction, portal vein resection with direct
reconstruction or grafting and removal of tumor
thrombus under direct vision as in this case. Survival of
more than 3 years after portal vein tumor thrombus
extraction for hepatocellular carcinoma has been re-
ported22.
In this patient, a carcinomatous thrombus of the left
portal vein from metastatic cutaneous melanoma to
the liver extended into the main portal vein without
invading the wall of the main portal vein. Thrombec-
tomy along with complete tumor resection and nega-
tive margins provided the best palliation and possibly
the prospect of long-time survival.
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